ID

42972

Description

A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by Rituximab; ODM derived from: https://clinicaltrials.gov/show/NCT00001805

Lien

https://clinicaltrials.gov/show/NCT00001805

Mots-clés

Versions (2)
  1. 06/01/2016 06/01/2016 -
  2. 17/09/2021 17/09/2021 -
Détendeur de droits

CC BY-NC 3.0

Téléchargé le

17 septembre 2021

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Breast Neoplasms NCT00001805

Anglais

Eligibility Breast Neoplasms NCT00001805

1 Formulaires  
Criteria
Description

Criteria

must have the presence of b3 antigen on the surface of greater than 30% of the tumor cells.
Description

presence of b3 antigen

Type de données

boolean

must be greater than or equal to 18 years old and be able to give informed consent.
Description

age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0021430
must have an ecog performance status of 0 or 1 and a minimum life expectancy of 3 months.
Description

ecog performance status

Type de données

boolean

Alias
UMLS CUI [1]
C1520224
UMLS CUI [2]
C0023671
must have normal renal function (creatinine less than or equal to 1.4 mg/dl), sgot and sgpt less than or equal to 2.5 x of the upper limits of normal. total bilirubin less than 1.5 mg/dl; agc greater than or equal to 1.5 x 10(3) microliter; platelets greater than 100,000 per mm(3).
Description

must have normal renal function (creatinine less than or equal to 1.4 mg/dl), sgot and sgpt less than or equal to 2.5 x of the upper limits of normal. total bilirubin less than 1.5 mg/dl; agc greater than or equal to 1.5 x 10(3) microliter; platelets greater than 100,000 per mm(3).

Type de données

boolean

Alias
UMLS CUI [1]
C0201976
UMLS CUI [2]
C0201899
UMLS CUI [3]
C0201836
UMLS CUI [4]
C1278039
UMLS CUI [5]
C0005821
must have recovered from the toxic effects of prior chemotherapy or radiation therapy. at least 3 weeks must have elapsed since the last dose of chemotherapy, hormonal therapy or radiation therapy. at least six weeks must have elapsed since the last dose of mitomycin c and a nitrosourea.
Description

must have recovered from the toxic effects of prior chemotherapy or radiation therapy. at least 3 weeks must have elapsed since the last dose of chemotherapy, hormonal therapy or radiation therapy. at least six weeks must have elapsed since the last dose of mitomycin c and a nitrosourea.

Type de données

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2]
C0279025
UMLS CUI [3]
C1522449
UMLS CUI [4]
C0002475
UMLS CUI [5]
C0028210
must not have serum neutralizing antibodies to lmb-1.
Description

serum neutralizing antibodies to lmb-1

Type de données

boolean

Alias
UMLS CUI [1]
C0796420
must not have positive hepatitis b surface antigen, hepatitis c antibody or hiv.
Description

hepatitis b surface antigen, hepatitis c antibody or hiv

Type de données

boolean

Alias
UMLS CUI [1]
C0019163
UMLS CUI [2]
C0019196
UMLS CUI [3]
C0019682
must not have a history of coronary artery disease, ny class ii-iv chf, arrhythmia requiring treatment and any contraindication to pressor therapy.
Description

must not have a history of coronary artery disease, ny class ii-iv chf, arrhythmia requiring treatment and any contraindication to pressor therapy.

Type de données

boolean

Alias
UMLS CUI [1]
C1956346
UMLS CUI [2]
C1275491
UMLS CUI [3]
C0003811
must not have fev1 and fvc less than or equal to 65% of the predicted value.
Description

must not have fev1 and fvc less than or equal to 65% of the predicted value.

Type de données

boolean

Alias
UMLS CUI [1]
C0748133
UMLS CUI [2]
C1287681
must not have baseline serum albumin of less than 3.0 g/dl.
Description

albumin

Type de données

boolean

Alias
UMLS CUI [1]
C0201838
must not have a history of cns metastasis and/or known seizure disorders, or concurrent malignancy.
Description

must not have a history of cns metastasis and/or known seizure disorders, or concurrent malignancy.

Type de données

boolean

Alias
UMLS CUI [1]
C0279130
UMLS CUI [2]
C0036572
UMLS CUI [3]
C0006826
must not have an acute bacterial infection that requires antibiotic therapy (unless infection is completely resolved).
Description

acute bacterial infection

Type de données

boolean

Alias
UMLS CUI [1]
C0009450
must not have any coexisting medical or psychiatric condition that is likely to interfere with study procedures and/or results.
Description

must not have any coexisting medical or psychiatric condition that is likely to interfere with study procedures and/or results.

Type de données

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C2348563
must not be pregnant or breastfeeding. patients of childbearing potential must agree to use an effective method of contraception.
Description

must not be pregnant or breastfeeding. patients of childbearing potential must agree to use an effective method of contraception.

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
must not have a history of allergic reaction to penicillin.
Description

allergic reaction to penicillin

Type de données

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0030842
must not have lymphoma.
Description

lymphoma

Type de données

boolean

Alias
UMLS CUI [1]
C0024299
Retour au début de la page

Similar models

Eligibility Breast Neoplasms NCT00001805

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
presence of b3 antigen
Item
must have the presence of b3 antigen on the surface of greater than 30% of the tumor cells.
boolean
age
Item
must be greater than or equal to 18 years old and be able to give informed consent.
boolean
C0001779 (UMLS CUI [1])
C0021430 (UMLS CUI [2])
ecog performance status
Item
must have an ecog performance status of 0 or 1 and a minimum life expectancy of 3 months.
boolean
C1520224 (UMLS CUI [1])
C0023671 (UMLS CUI [2])
must have normal renal function (creatinine less than or equal to 1.4 mg/dl), sgot and sgpt less than or equal to 2.5 x of the upper limits of normal. total bilirubin less than 1.5 mg/dl; agc greater than or equal to 1.5 x 10(3) microliter; platelets greater than 100,000 per mm(3).
Item
must have normal renal function (creatinine less than or equal to 1.4 mg/dl), sgot and sgpt less than or equal to 2.5 x of the upper limits of normal. total bilirubin less than 1.5 mg/dl; agc greater than or equal to 1.5 x 10(3) microliter; platelets greater than 100,000 per mm(3).
boolean
C0201976 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
C1278039 (UMLS CUI [4])
C0005821 (UMLS CUI [5])
must have recovered from the toxic effects of prior chemotherapy or radiation therapy. at least 3 weeks must have elapsed since the last dose of chemotherapy, hormonal therapy or radiation therapy. at least six weeks must have elapsed since the last dose of mitomycin c and a nitrosourea.
Item
must have recovered from the toxic effects of prior chemotherapy or radiation therapy. at least 3 weeks must have elapsed since the last dose of chemotherapy, hormonal therapy or radiation therapy. at least six weeks must have elapsed since the last dose of mitomycin c and a nitrosourea.
boolean
C0392920 (UMLS CUI [1])
C0279025 (UMLS CUI [2])
C1522449 (UMLS CUI [3])
C0002475 (UMLS CUI [4])
C0028210 (UMLS CUI [5])
serum neutralizing antibodies to lmb-1
Item
must not have serum neutralizing antibodies to lmb-1.
boolean
C0796420 (UMLS CUI [1])
hepatitis b surface antigen, hepatitis c antibody or hiv
Item
must not have positive hepatitis b surface antigen, hepatitis c antibody or hiv.
boolean
C0019163 (UMLS CUI [1])
C0019196 (UMLS CUI [2])
C0019682 (UMLS CUI [3])
must not have a history of coronary artery disease, ny class ii-iv chf, arrhythmia requiring treatment and any contraindication to pressor therapy.
Item
must not have a history of coronary artery disease, ny class ii-iv chf, arrhythmia requiring treatment and any contraindication to pressor therapy.
boolean
C1956346 (UMLS CUI [1])
C1275491 (UMLS CUI [2])
C0003811 (UMLS CUI [3])
must not have fev1 and fvc less than or equal to 65% of the predicted value.
Item
must not have fev1 and fvc less than or equal to 65% of the predicted value.
boolean
C0748133 (UMLS CUI [1])
C1287681 (UMLS CUI [2])
albumin
Item
must not have baseline serum albumin of less than 3.0 g/dl.
boolean
C0201838 (UMLS CUI [1])
must not have a history of cns metastasis and/or known seizure disorders, or concurrent malignancy.
Item
must not have a history of cns metastasis and/or known seizure disorders, or concurrent malignancy.
boolean
C0279130 (UMLS CUI [1])
C0036572 (UMLS CUI [2])
C0006826 (UMLS CUI [3])
acute bacterial infection
Item
must not have an acute bacterial infection that requires antibiotic therapy (unless infection is completely resolved).
boolean
C0009450 (UMLS CUI [1])
must not have any coexisting medical or psychiatric condition that is likely to interfere with study procedures and/or results.
Item
must not have any coexisting medical or psychiatric condition that is likely to interfere with study procedures and/or results.
boolean
C0009488 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,3])
must not be pregnant or breastfeeding. patients of childbearing potential must agree to use an effective method of contraception.
Item
must not be pregnant or breastfeeding. patients of childbearing potential must agree to use an effective method of contraception.
boolean
C0032961 (UMLS CUI [1])
allergic reaction to penicillin
Item
must not have a history of allergic reaction to penicillin.
boolean
C0020517 (UMLS CUI [1,1])
C0030842 (UMLS CUI [1,2])
lymphoma
Item
must not have lymphoma.
boolean
C0024299 (UMLS CUI [1])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial